NCT03040830

Brief Summary

The study aims to know whether starting progesterone luteal support in intra cytoplasmic sperm injection (ICSI) cycles on the day of ovum pickup affects the degree of difficulty of embryo transfer compared with starting luteal support on day of embryo transfer

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Nov 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

January 30, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 2, 2017

Completed
Last Updated

February 2, 2017

Status Verified

January 1, 2017

Enrollment Period

12 months

First QC Date

January 30, 2017

Last Update Submit

February 1, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • difficult embryo transfer

    presence of blood on embryo transfer catheter and or need for sounding or dilating the cervix to pass the embryo transfer catheter to the endometrial cavity

    3 minutes

Secondary Outcomes (1)

  • cycle outcome

    4 weeks

Study Arms (2)

Egg retrieval arm

EXPERIMENTAL

67 ICSI cases are started daily 100 mg IM prontogest on the day of egg retrieval until the day of pregnancy test.

Drug: Progesterone 100 IM/day

Embryo transfer arm

ACTIVE COMPARATOR

66 ICSI cases are started daily 100 mg IM prontogest on the day of embryo transfer until the day of pregnancy test.

Drug: Progesterone 100 IM/day

Interventions

Progesterone IM 100 mg /day was started on day of egg retrieval in egg retrieval arm and on day of embryo transfer in the embryo transfer arm

Egg retrieval armEmbryo transfer arm

Eligibility Criteria

Age18 Years - 38 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsinfertile females undergoing first ICSI cycle
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • first ICSI trial, normal uterus, normal cervix, normal ovarian response ,easy mock transfer,patient consenting

You may not qualify if:

  • age over 38, difficult mock transfer, low and high ovarian response, patient not consenting

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Mochtar MH, Van Wely M, Van der Veen F. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles. Hum Reprod. 2006 Apr;21(4):905-8. doi: 10.1093/humrep/dei437. Epub 2005 Dec 22.

    PMID: 16373409BACKGROUND
  • Senciboy D.N and Sharpe-Timms K.L: Progesterone affects the cervix prior to embryo transfer. , Fertility and Sterility ,2001: 76 , Issue 3 , S220 - S221

    BACKGROUND
  • Ghanem ME, Ragab AE, Alboghdady LA, Helal AS, Bedairy MH, Bahlol IA, Abdelaziz A. Difficult embryo transfer (ET) components and cycle outcome. Which is more harmful?. Middle East Fertility Society Journal. 2016 Jun 30;21(2):114-119

    BACKGROUND
  • Ghanem ME, Bedairy MH, Shaaban A, Albahlol IA. Does the Time of Starting Progesterone Luteal Support Affect Embryo Transfer in Long Agonist Protocol Downregulated ICSI Cycles? A Randomized Controlled Trial. Reprod Sci. 2021 Mar;28(3):897-903. doi: 10.1007/s43032-020-00309-0. Epub 2020 Sep 9.

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
The randomization
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Double blind Randomized Controlled Trial : the clinicians and the patents were blinded of the allocation group. A total of 137 embryo transfers (ETs) were randomly allocated into either group A (67 ) starting luteal support as daily intra muscular (IM) injections of 100 mg prontogest on day of egg retrieval, or group B (66) starting the same P4 dose on day of embryo transfer.Transfer technique was blind tactile using Labotect catheter and was considered difficult if the inner ET catheter was blood stained and /or sounding or dilating the cervix was needed. Cervical traction or blood staining of outer sheath did not indicate difficulty
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 30, 2017

First Posted

February 2, 2017

Study Start

November 1, 2015

Primary Completion

October 30, 2016

Study Completion

January 1, 2017

Last Updated

February 2, 2017

Record last verified: 2017-01